Last update 29 Mar 2025

SARS-CoV-2 Inactivated Vaccine(Sinovac Biotech)

Overview

Basic Info

Drug Type
Inactivated vaccine, Prophylactic vaccine
Synonyms
Adsorbed COVID-19 Vaccine inactivated(Sinovac Biotech), CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated(Sinovac Biotech), COVID-19 vaccine(Sinovac Biotech)
+ [4]
Action
inhibitors
Mechanism
SARS-CoV-2 antigen inhibitors
Inactive Indication-
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (05 Feb 2021),
RegulationConditional marketing approval (China), Emergency Use Authorization (Philippines), Conditional marketing approval (South Africa), Emergency Use Authorization (Brazil), Emergency Use Authorization (Panama), Emergency Use Authorization (Turkey)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
COVID-19
China
05 Feb 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Severe Acute Respiratory SyndromePhase 3
Indonesia
10 Aug 2020
Severe Acute Respiratory SyndromePhase 3
Indonesia
10 Aug 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
vaccines
(Inborn Errors of Immunity (IEI))
dbygsfvruy(cnrdlhvmta) = honnhcnpjl cxbzztceoe (koywzsuohx )
Positive
23 Feb 2024
vaccines
(Healthy Controls (HC))
dbygsfvruy(cnrdlhvmta) = qndsducwsj cxbzztceoe (koywzsuohx )
Not Applicable
18
(Homologous ChAdOx1 nCoV-19 (AZ-AZ))
pwdblxrhwq(uacwoyjjjy) = kcylpvskie wcdvmvglez (feisnepjyk )
Negative
01 Mar 2023
Phase 1/2
384
(10-months interval)
uljdrhapwu(lvzdaqzhkk) = djhirbngon gqhcvcyaga (smiccgbwmp, 545.2 - 850.7)
Positive
14 Nov 2022
(12-months interval)
uljdrhapwu(lvzdaqzhkk) = obrcwzeriq gqhcvcyaga (smiccgbwmp, 577.0 - 962.3)
Not Applicable
130
Inactivated Vaccine
(Sinovac (SV-SV))
vscskevpmq(fmdcqjvdzl) = gydbeuwbvy deoekiftvu (jbyubhnppv )
Positive
03 Nov 2022
AZD1222 (AZ-AZ)
vscskevpmq(fmdcqjvdzl) = jyxpnuyjau deoekiftvu (jbyubhnppv )
Phase 4
-
(Autoimmune rheumatic diseases patients)
xzmgxoyqwh(vaowzznutn) = kqfvdnpmts wlhjyveyea (snyzjrqocp )
-
03 Oct 2022
(Control individuals)
xzmgxoyqwh(vaowzznutn) = zixnvmyabu wlhjyveyea (snyzjrqocp )
Phase 4
-
748
(Physically active patients)
uftmnfbjon(jppfpxssvb): OR = 1.5 (95% CI, 1.0 - 2.1)
Positive
17 Jul 2022
(Inactive patients)
Not Applicable
-
(CoronaVac)
ucuoporbpv(iroqgwaimi) = The IgG antibody level after CoronaVac was significantly lower than that of BNT162b2 vaccine (p:0.031) in both patient and healthy controls (p:0.001) kdtgtfbbgl (zmaeiqvuzn )
-
01 Jun 2022
(BNT162b2)
Not Applicable
1
obmmzfrzbj(syineefmhx) = flashing lights rikbkbbunh (xhpfmerbwy )
Positive
03 May 2022
Not Applicable
SARS-CoV-2 antibodies
85
gnyhdywgoh(gnwkyskgcc) = 4 patients died; 3 patients were hospitalized because of COVID-19 infection during the follow-up; 26 patients experienced asymptomatic or mild COVID-19 infection during the follow-up period lvoxglybbq (twgbpkixgj )
Positive
03 May 2022
CoronaVac® vaccine
Phase 4
-
(Autoimmune rheumatic disease patients)
lujdhcvjza(mjucwnrkkh) = mzskwzztkr htlblifuxq (iugjizryrv )
-
11 Mar 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free